About BacterOMIC
BacterOMIC is a company based in Warsaw (Poland) founded in 2017. BacterOMIC offers products and services including BACTEROMIC System, Universal Panel, and Custom AST Panel. BacterOMIC operates in a competitive market with competitors including Rapid Micro Biosystems and Rapiddx Technologies, among others.
- Headquarter Warsaw, Poland
- SectorsHealthcare
- Email••••••••
- Phone•••• ••••
- Website bacteromic.com
- Legal Name Bacteromic Spółka Z Ograniczoną Odpowiedzialnością
- Net Profit-$369.7 K (USD)15as on Dec 31, 2020
- EBITDA$3.14 K (USD)-42as on Dec 31, 2020
- Latest Funding Round$2.13M (USD), Grant
Aug 2019
- Investors
Products & Services of BacterOMIC
BacterOMIC offers a comprehensive portfolio of products and services, including BACTEROMIC System, Universal Panel, and Custom AST Panel.
Evaluates antibiotic effectiveness against bacterial infections.
Assesses susceptibility directly from positive blood cultures.
Provides tailored testing for animal pathogen resistance.
Funding Insights of BacterOMIC
- Total Rounds 1
- Last Round Grant — $2.13M
- First Round $2.13M
(Aug 2019)
- Investors Count 1
All 1 funding rounds of BacterOMIC with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Aug 2019 | $2.13M | Grant | – | – |
1 investors in total: 1 institutional.
Investors in BacterOMIC
BacterOMIC has secured backing from 1 investor, including institutional investors. Prominent investors backing the company include European Union.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Government entites focused on freedom, democracy, equality and the rule of law, promoting peace and stability | 1958 | europa.eu | Brussels, Belgium |
Investor details for BacterOMIC
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of BacterOMIC
4 people are tracked at BacterOMIC (2 in leadership, 2 in team).
| Name | Role | Group |
|---|---|---|
Bernd Eberhardt | CEO | Leadership |
Szymon Ruta | Chief Financial Officer | Leadership |
Anna S. | Manager Ds. Finansowych | Team |
Łukasz Richter | Product Manager | Team |
Complete people profiles for BacterOMIC
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Timeline of BacterOMIC
2 dated milestones of BacterOMIC across 2 years, from founding to its latest funding, stage changes and deals.
- Founded BacterOMIC is founded.
- Funding First funding round of $2.1M.
Competitors of BacterOMIC
BacterOMIC operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Rapid Micro Biosystems and Rapiddx Technologies, among others.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| rapidmicrobio.com | 2006 | Bedford, United Kingdom | $349.7M | 202 | Biosystems for microbial contamination detection are developed and supplied. | |
| rapiddxtech.com | 2019 | Bengaluru, India | – | – | Antimicrobial susceptibility platform is developed via microfluidics and sensor technology. |
Detailed competitors of BacterOMIC
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Bacteromic
Complete news archive for BacterOMIC
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Similar companies to BacterOMIC
10 companies that operate in the same segment as BacterOMIC (Life Sciences Platforms & Tools), ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Medidata is recognized as a leading provider of SaaS solutions for clinical research. | 1999 | New York, New York, United States | USD 41.5 M | – | – | |
AI-based solutions for health management are provided. | 2015 | Dallas, Texas, United States | USD 2.8 B | – | – | |
Nanopore-based electronic systems for single-molecule analysis are developed. | 2005 | Oxford, Oxfordshire, United Kingdom | USD 1.3 B | USD 301.49 M | 1,480 | |
Real-world health data is provided for research and decisions. | 2012 | Menlo Park, California, United States | USD 259.16 M | – | – | |
Genetically modified cell lines are developed using AAV gene-editing platform. | 2007 | Cambridge, Cambridgeshire, United Kingdom | USD 46.29 M | – | – | |
Biological reagents and antibodies are developed for life science research. | 1998 | Cambridge, Cambridgeshire, United Kingdom | USD 78.8 M | – | – | |
Electron microscopy services and microanalysis instruments are provided. | 1956 | Waltham, Massachusetts, United States | – | USD 44.56 B | 125,000 | |
Novel therapeutics are discovered using an AI-enabled drug platform. | 2013 | New York, New York, United States | USD 456.66 M | USD 74.68 M | – | |
A platform for sharing and accessing academic research papers is provided. | 2008 | San Francisco, California, United States | USD 58.4 M | – | – | |
Developer of molecular diagnostic testing solutions | 1996 | Sunnyvale, California, United States | USD 19.1 M | USD 54.88 M | 208 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about BacterOMIC
BacterOMIC was founded in 2017 and raised its 1st funding round 2 years after it was founded.
BacterOMIC is headquartered in Warsaw, Poland.
Developer of a system for antibiotic susceptibility testing. The system has a disposable panel that contains various antibiotics and a checkerboard combination of antibiotics. It is developed by combining microfluidics, detection, data analysis, and automation which helps in determining the treatment of MDR pathogens.
BacterOMIC's top competitors include Rapid Micro Biosystems and Rapiddx Technologies.
BacterOMIC offers BACTEROMIC System, Universal Panel, and Custom AST Panel.
BacterOMIC has 1 investor. Key investors include European Union.
BacterOMIC operates through Bacteromic Spółka Z Ograniczoną Odpowiedzialnością.